drugset / Trial / NCT00755911

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

NCT00755911 ↗

Phase 1/2 Completed 24 enrolled University of Michigan Vericel Corporation · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Cell (TRC) Therapy.

Timeline

Start
2008-06
Primary completion
2011-12
Completion
2012-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tissue Repair Cells Cell therapy 10 ml Other

Indications